PharmaVoice
1,344 FOLLOWERS
PharmaVoice offers multiple channels for brand enhancement, thought-leadership positioning, and lead generation to the pharma, biotech, and med device industry.
PharmaVoice
8h ago
Chris Boshoff will replace Mikael Dolsten, who’s stepping down after 15 years leading research at the drugmaker ..read more
PharmaVoice
8h ago
A subcutaneous version of Merck’s Keytruda was as effective as the infused version in a late-stage study, but the company won’t be the first to market ..read more
PharmaVoice
1d ago
It’s still likely U.S. biotechs and pharmas will have to cut ties with key Chinese partners — it’s just a matter of when.
..read more
PharmaVoice
1d ago
The company is looking to score an FDA nod for its investigational therapy that targets a molecule linked to Guillain-Barré syndrome and other autoimmune diseases ..read more
PharmaVoice
1d ago
AbbVie’s head of R&D cures has lofty ambitions to end diseases like HIV through a community of researchers that work as one ..read more
PharmaVoice
3d ago
Merck’s acquisition of Modifi Biosciences bucks common M&A trends in pharma. ..read more
PharmaVoice
3d ago
With only one approved drug on the market, companies like Inventiva Pharma are advancing MASH drugs and seeking a competitive edge ..read more
PharmaVoice
6d ago
If confirmed to the role, Robert F. Kennedy Jr. would oversee the country's top health agencies, including the Food and Drug Administration and the Centers for Disease Control and Prevention. ..read more
PharmaVoice
6d ago
How Novavax and others have restructured and trudged forward after their COVID-era high ..read more
PharmaVoice
1w ago
While Martin Shkreli smirked his way through a public securities fraud investigation, Ron Tilles became interim CEO of Turing Pharmaceuticals, ready or not. Here’s his story ..read more